We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UTL:NYSEUNITIL Corporation Analysis

Data as of 2026-08-31 - not real-time

$53.19

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Unitil Corporation trades at $53.19, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it lost 2.1%. With RSI at 44.4 the momentum picture is neutral, alongside a bearish MACD signal. Watch $51.98 as support and $54.96 as the nearer resistance level.
Valuation screens as fair: a P/E of 16.9 sits below the sector average of 19.2. Sell-side targets cluster 4.0% above the current quote. Revenue is growing at 14.0% on a 9.5% profit margin. The 3.55% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 15.0%, a beta of -0.16 and a maximum drawdown of 11.7%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 4/10 conviction.

Top Market Events

HAMPTON, N.H., July 21, 2026 GLOBE NEWSWIRE -- Unitil Corporation NYSE: UTL unitil.com has scheduled the release of its...HAMPTON, N.H., July 21, 2026 GLOBE NEWSWIRE -- Unitil Corporation NYSE: UTL unitil.com has scheduled the release of its...HAMPTON, N.H., Aug. 03, 2026 GLOBE NEWSWIRE -- Unitil Corporation NYSE: UTL unitil.com Unitil or the Company today...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 51.60
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 16.9 versus sector average of 19.2
  • Trading above the 200-day average of 51.60

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 16.9 versus sector average of 19.2
  • Revenue growth of +14.0%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth14.00%
Profit Margin9.49%
P/E Ratio16.9
ROE9.62%
ROA3.48%
Debt/Equity149.59
P/B Ratio1.6
Op. Cash Flow$142.8M
Free Cash Flow$-65891876
Industry P/E19.2

Technical Analysis

TrendBullish
RSI44.4
Support$51.98
Resistance$54.96
MA 20$53.73
MA 50$53.69
MA 200$51.60
MACDBearish
VolumeIncreasing
Fear & Greed Index94.46

Valuation

Fair Value$73.63
Target Price$55.33
Upside/Downside4.03%
GradeFair
TypeBlend
Dividend Yield3.55%

Risk Assessment

Beta-0.16
Volatility14.99%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.